CoChat

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression

Open access
Weiss, Brandon, Ginige, Induni, Shannon, Lu, Giribaldi, Bruna, Murphy-Beiner, Ashleigh, Murphy, Roberta, Baker-Jones, Michelle, Martell, Jonny, Nutt, David J., Carhart-Harris, Robin L., Erritzoe, David · 2024 · Psychological Medicine
Cited by 40

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Background: Psilocybin Therapy (PT) is being increasingly studied as a psychiatric intervention. Personality relates to mental health and can be used to probe the nature of PT's therapeutic action. Methods: In a phase 2, double-blind, randomized, active comparator controlled trial involving patients with moderate-to-severe major depressive disorder, we compared psilocybin with escitalopram, over a core 6-week trial period. Five-Factor model personality domains, Big Five Aspect Scale Openness aspects, Absorption, and Impulsivity were measured at Baseline, Week 6, and Month 6 follow-up. Results: PT was associated with decreases in neuroticism (B= −0.63), introversion (B= −0.38), disagreeableness (B= −0.47), impulsivity (B= −0.40), and increases in absorption (B= 0.32), conscientiousness (B= 0.30), and openness (B= 0.23) at week 6, with neuroticism (B= −0.47) and disagreeableness (B= −0.41) remaining decreased at month 6. Escitalopram Treatment (ET) was associated with decreases in neuroticism (B= −0.38), disagreeableness (B= −0.26), impulsivity (B= −0.35), and increases in openness (B= 0.28) at week 6, with neuroticism (B= −0.46) remaining decreased at month 6. No significant between-condition differences were observed. Conclusions: Personality changes across both conditions were in a direction consistent with improved mental health. With the possible exception of trait absorption, there were no compelling between-condition differences warranting conclusions regarding a selective action of PT (v.ET) on personality; however, post-ET changes in personality were significantly moderated by pre-trial positive expectancy for escitalopram, whereas expectancy did not moderate response to PT.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1017/s0033291723001514

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 40

Metadata

Authors
Weiss, B., Ginige, I., Shannon, L., Giribaldi, B., Murphy-Beiner, A., Murphy, R., Baker-Jones, M., Martell, J., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D.
Venue
Psychological Medicine
Published
2023-06-02
Volume
54
Issue
1
Pages
178-192
ISSN
  • 0033-2917 (ISSN-L)
  • 1469-8978
OpenAlex
W4379093876
Cited by
40
References
57
FWCI
10.97
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression. https://app.cochat.ai/papers/10.1017/s0033291723001514
The paper
Weiss, B., Ginige, I., Shannon, L., Giribaldi, B., Murphy-Beiner, A., Murphy, R., Baker-Jones, M., Martell, J., Nutt, D. J., Carhart-Harris, R. L., & Erritzoe, D. (2024). Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression. Psychological Medicine. https://doi.org/10.1017/s0033291723001514

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.